Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automat-ed Radiopharmaceutical Preparation and Administration System

Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automated Radiopharmaceutical Preparation and Administration System

This project aims to evaluate the impact of the introduction of an automated system for radiopharmaceutical preparation and administration on the radiation safety of the radiographers working in nuclear medicine. This study will help to fill the existing gap in the scientific literature and provide useful guidance for the selection of the safest and most effective automated infusion system.

Study Overview

• Status: Not yet recruiting
• Conditions: Radiation Exposure
• Intervention / Treatment: Radiation: automated system in reducing radiation exposure

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Giuseppe Bonfitto; Phone Number: 02-26438384; Email: bonfitto.giuseppe@hsr.it
• Study Contact Backup: Name: Serena Pichierri; Phone Number: 02-26438384; Email: pichierri.serena@hsr.it

Study Locations

• Italy
  • Milano, Italy
    • IRCCS San Raffaele

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Healthcare professionals working in nuclear medicine departments

Description

Inclusion Criteria:

• 1)Nuclear medicine radiographers with experience in manual prepa-ration of radiopharmaceuticals.

  2) Nuclear medicine healthcare professionals with experience in radiopharmaceutical administration.

  3) Ability to provide written informed consent.

Exclusion Criteria:

• 1) Nuclear medicine radiographers without experience in manual preparation of radiopharmaceuticals.

  2) Nuclear medicine healthcare professionals without experience in radiopharmaceutical administration.

  3) Inability to provide written informed consent.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Change in absorbed dose by radiographers during PET/CT procedures, measured in millisieverts (mSv).	3 months

Collaborators and Investigators

• Sponsor: IRCCS San Raffaele
• Investigators: Study Director: Arturo Chiti, Irccs Ospedale San Raffaele

Study record dates

Study Major Dates

• Study Start (Estimated): October 1, 2024
• Primary Completion (Estimated): October 1, 2024
• Study Completion (Estimated): October 1, 2024

Study Registration Dates

• First Submitted: April 10, 2024
• First Submitted That Met QC Criteria: April 15, 2024
• First Posted (Actual): April 17, 2024

Study Record Updates

• Last Update Posted (Actual): October 3, 2024
• Last Update Submitted That Met QC Criteria: October 2, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: PETCT_INTEGO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No